Current and novel biomarkers in anti-neutrophil cytoplasm-associated vasculitis

Anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) is characterized by a variable disease course, with up to 50% of patients having one relapse within 5 years and many progressing to end-stage organ damage despite modern treatment strategies. Moreover, complications arising from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Draibe, Juliana Bordignon, Fulladosa, Xavier, Cruzado, Josep Maria, Torras, Joan, Salama, Alan David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Kidney in Systemic Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957731/
https://www.ncbi.nlm.nih.gov/pubmed/27478594
http://dx.doi.org/10.1093/ckj/sfw056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957731/
https://www.ncbi.nlm.nih.gov/pubmed/27478594
http://dx.doi.org/10.1093/ckj/sfw056

Ejemplares similares